| Empagliflozin reduces the levels of CD36 and cardiotoxic lipids while improving autophagy in the hearts of Zucker diabetic fatty rats A Aragon-Herrera, S Feijoo-Bandin, MO Santiago, L Barral, ... Biochemical Pharmacology 170, 113677, 2019 | 142 | 2019 |
| Adipokines and inflammation: focus on cardiovascular diseases S Feijóo-Bandín, A Aragón-Herrera, S Moraña-Fernández, ... International journal of molecular sciences 21 (20), 7711, 2020 | 81 | 2020 |
| Role of sodium-glucose co-transporter 2 inhibitors in the regulation of inflammatory processes in animal models S Feijóo-Bandín, A Aragón-Herrera, M Otero-Santiago, L Anido-Varela, ... International Journal of Molecular Sciences 23 (10), 5634, 2022 | 32 | 2022 |
| Relaxin-2 in cardiometabolic diseases: mechanisms of action and future perspectives S Feijóo-Bandín, A Aragón-Herrera, D Rodríguez-Penas, M Portolés, ... Frontiers in physiology 8, 599, 2017 | 32 | 2017 |
| Relaxin activates AMPK-AKT signaling and increases glucose uptake by cultured cardiomyocytes A Aragón-Herrera, S Feijóo-Bandín, D Rodríguez-Penas, E Roselló-Lletí, ... Endocrine 60, 103-111, 2018 | 21 | 2018 |
| Relaxin-2 as a potential biomarker in cardiovascular diseases A Aragón-Herrera, S Feijóo-Bandín, L Anido-Varela, ... Journal of personalized medicine 12 (7), 1021, 2022 | 19 | 2022 |
| Serelaxin (recombinant human relaxin-2) treatment affects the endogenous synthesis of long chain poly-unsaturated fatty acids and induces substantial alterations of lipidome … A Aragon-Herrera, S Feijoo-Bandin, V Abella, L Alvarez, E Rosello-Lleti, ... Pharmacological Research 144, 51-65, 2019 | 14 | 2019 |
| Injectable hybrid hydrogels physically crosslinked based on carrageenan and green graphene for tissue repair D Moncada, M Rico, B Montero, S Rodríguez-Llamazares, ... International Journal of Biological Macromolecules 235, 123777, 2023 | 10 | 2023 |
| The lipidomic and inflammatory profiles of visceral and subcutaneous adipose tissues are distinctly regulated by the SGLT2 inhibitor empagliflozin in Zucker diabetic fatty rats A Aragón-Herrera, S Moraña-Fernández, M Otero-Santiago, ... Biomedicine & Pharmacotherapy 161, 114535, 2023 | 9 | 2023 |
| Metabolic alterations derived from absence of Two-Pore Channel 1 at cardiac level V García-Rúa, S Feijóo-Bandín, M García-Vence, A Aragón-Herrera, ... Journal of biosciences 41, 643-658, 2016 | 8 | 2016 |
| Relaxin has beneficial effects on liver lipidome and metabolic enzymes A Aragón‐Herrera, S Feijóo‐Bandín, S Moraña‐Fernández, ... The FASEB Journal 35 (7), e21737, 2021 | 7 | 2021 |
| Relaxin-2 plasma levels in atrial fibrillation are linked to inflammation and oxidative stress markers A Aragón-Herrera, M Couselo-Seijas, S Feijóo-Bandín, L Anido-Varela, ... Scientific reports 12 (1), 22287, 2022 | 6 | 2022 |
| The treatment with the SGLT2 inhibitor empagliflozin modifies the hepatic metabolome of male Zucker diabetic fatty rats towards a protective profile A Aragón-Herrera, M Otero-Santiago, L Anido-Varela, ... Frontiers in Pharmacology 13, 827033, 2022 | 6 | 2022 |
| Circulating miR-451a expression may predict recurrence in atrial fibrillation patients after catheter pulmonary vein ablation R Lage, M Cebro-Márquez, ME Vilar-Sánchez, L González-Melchor, ... Cells 12 (4), 638, 2023 | 5 | 2023 |
| Cardiac sodium/hydrogen exchanger (NHE11) as a novel potential target for SGLT2i in heart failure: a preliminary study L Pérez-Carrillo, A Aragón-Herrera, I Giménez-Escamilla, ... Pharmaceutics 14 (10), 1996, 2022 | 5 | 2022 |
| A summary about relaxin and its reproductive function A Aragon-Herrera, S Feijóo-Bandín, D Rodríguez-Penas Endocrinol Metab Int J 4 (5), 114-116, 2017 | 5 | 2017 |
| Plasma miR-486-5p Expression Is Upregulated in Atrial Fibrillation Patients with Broader Low-Voltage Areas M Cebro-Márquez, M Rodríguez-Mañero, V Serrano-Cruz, ... International Journal of Molecular Sciences 24 (20), 15248, 2023 | 2 | 2023 |
| Human recombinant relaxin-2 (serelaxin) regulates the proteome, lipidome, lipid metabolism and inflammatory profile of rat visceral adipose tissue A Aragón-Herrera, S Feijóo-Bandín, X Vázquez-Abuín, L Anido-Varela, ... Biochemical Pharmacology 223, 116157, 2024 | 1 | 2024 |
| Meteorin-like plasma levels as a novel biomarker for heart failure L Anido Varela, A Aragon-Herrera, E Tarazon, E Sole-Gonzalez, ... European Heart Journal 44 (Supplement_2), ehad655. 1111, 2023 | 1 | 2023 |
| Circulating miR-451a Expression May Predict Recurrence in Atrial Fibrillation Patients after Catheter Pulmonary Vein Ablation. Cells 2023; 12 R Lage, M Cebro-Márquez, ME Vilar-Sánchez, L González-Melchor, ... | 1 | 2023 |
